Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumorsVanesa Gregorc, Filippo G De Braud, Tommaso M De Pas, et al.
Future Oncology (London, England)|April 3, 2015
Molecular features and clinical outcome of lung malignancies in very young peopleChiara Catania, Edoardo Botteri, Massimo Barberis, et al.
Expert Review of Anticancer Therapy|November 1, 2025
Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspectiveGiuseppe Pelosi, Alice Laffi, Gianpiero Catalano, et al.
JNCI Cancer Spectrum|August 20, 2025
Heterogeneity of progression-free-survival surrogacy by sex in randomized trials testing immunotherapy in NSCLCEleonora Pagan, Isabella Sala, Laura Pala, et al.
Eclinicalmedicine|July 15, 2024
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisLaura Pala, Eleonora Pagan, Isabella Sala, et al.
The Lancet. Oncology|September 12, 2022
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trialFabio Conforti, Paolo Andrea Zucali, Laura Pala, et al.
Cell Adhesion & Migration|January 7, 2015
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancerChiara Catania, Michela Maur, Rossana Berardi, et al.
Journal of the National Cancer Institute|March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugatesLaura Pala, Federico Merlo, Isabella Sala, et al.
Cancers|January 25, 2025
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME)Chiara Catania, Sara Manglaviti, Paolo Zucali, et al.
Critical Reviews in Oncology/Hematology|February 3, 2025
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION groupChiara Catania, Claudia Proto, Chiara Bennati, et al.
Pageof 8